Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,786,701 papers from all fields of science
Search
Sign In
Create Free Account
etoposide phosphate
Known as:
ETOP
, etoposide phosphate [Chemical/Ingredient]
A phosphate salt of a semisynthetic derivative of podophyllotoxin. Etoposide binds to the enzyme topoisomerase II, inducing double-strand DNA breaks…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
28 relations
Broader (3)
Antineoplastic Agents
Etoposide
Organophosphorus Compounds
Narrower (3)
BMY-40481
Etophos
Etopophos
Bladder Neoplasm
Brain Neoplasms
Chronic Lymphocytic Leukemia
Drug Allergy
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Characterizing the Active Opening of the Eustachian Tube in a Hypobaric/Hyperbaric Pressure Chamber
S. Mikolajczak
,
M. Meyer
,
+6 authors
D. Beutner
Otology and Neurotology
2014
Corpus ID: 32469216
Objective Active and passive opening of the Eustachian tube (ET) enables direct aeration of the middle ear and a pressure balance…
Expand
2009
2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C).
P. Shami
,
A. Maciąg
,
+4 authors
L. Keefer
Leukemia research : a Forum for Studies on…
2009
Corpus ID: 34464520
2004
2004
Quantification of etoposide and etoposide phosphate in human plasma by micellar electrokinetic chromatography and near-field thermal lens detection.
N. Ragozina
,
M. Pütz
,
S. Heissler
,
W. Faubel
,
U. Pyell
Analytical Chemistry
2004
Corpus ID: 38097803
A method employing micellar electrokinetic chromatography in combination with near-field thermal lens detection (NF-TLD) was…
Expand
Highly Cited
2002
Highly Cited
2002
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
H. Katzenstein
,
W. London
,
+4 authors
L. Bowman
Journal of Clinical Oncology
2002
Corpus ID: 11293628
PURPOSE To estimate the disease-response rate, proportion of patients whose tumors can be made resectable, event-free survival…
Expand
2001
2001
Simultaneous quantification of etoposide and etoposide phosphate in human plasma by capillary electrophoresis using laser-induced native fluorescence detection.
U. B. Soetebeer
,
M. Schierenberg
,
H. Schulz
,
G. Hempel
,
P. Andresen
,
G. Blaschke
Analytical Chemistry
2001
Corpus ID: 25807728
A method using capillary electrophoresis with UV laser-induced native fluorescence detection was developed as a sensitive and…
Expand
1999
1999
Successful Rechallenge with Etoposide Phosphate after an Acute Hypersensitivity Reaction to Etoposide
B. Bernstein
,
M. Troner
Pharmacotherapy
1999
Corpus ID: 22825615
Hypersensitivity reactions to etoposide are reported infrequently and consist of hypotension, hypertension, flushing, diaphoresis…
Expand
1998
1998
Separation of etoposide phosphate and methotrexate by capillary zone electrophoresis using UV detection with a high sensitivity cell
Y. Mrestani
,
R. Neubert
Electrophoresis
1998
Corpus ID: 1122462
Etoposide phosphate and methotrexate are important anti‐tumor chemotherapeutic agents. Our previously presented capillary zone…
Expand
1996
1996
Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients.
S. Kaul
,
N. Srinivas
,
V. Mummaneni
,
L. Igwemezie
,
R. Barbhaiya
Seminars in Oncology
1996
Corpus ID: 732272
The influence of gender, age, and race on the pharmacokinetics of etoposide and on the extent of conversion of etoposide…
Expand
1995
1995
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
S. Fields
,
L. Igwemezie
,
+7 authors
R. Barbhaiya
Clinical Cancer Research
1995
Corpus ID: 10202733
Etoposide phophate is a phosphate ester prodrug of etoposide designed to improve the pharmaceutical characteristics of the parent…
Expand
1995
1995
Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors.
S. Kaul
,
L. Igwemezie
,
+7 authors
P. O'dwyer
Journal of Clinical Oncology
1995
Corpus ID: 22123386
PURPOSE To assess the pharmacokinetics and bioequivalence of etoposide following intravenous (i.v.) administration of etoposide…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE